Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 25;16(2):e0247584. doi: 10.1371/journal.pone.0247584

Clinical significance of hypoalbuminemia in patients with scrub typhus complicated by acute kidney injury

Ju Hwan Oh 1, Ji Hye Lim 1, A Young Cho 1, Kwang Young Lee 1, In O Sun 1,*
Editor: Bhagwan Dass2
PMCID: PMC7906298  PMID: 33630937

Abstract

Background

This study aimed to investigate the clinical significance of hypoalbuminemia (HA) in patients with scrub typhus complicated by acute kidney injury (AKI).

Methods

From 2009 to 2018, 611 patients were diagnosed with scrub typhus. We divided the patients into two groups [normoalbuminemia (NA) vs. HA] based on the serum albumin level of 3.0 g/dL and compared the incidence, clinical characteristics, and severity of AKI based on the RIFLE classification between the two groups.

Results

Of the total 611 patients, 78 (12.8%) were categorized into the HA group. Compared to patients in the NA group, patients in the HA group were older (73 ± 9 vs. 62 ± 14 years, P<0.001). The HA group had a significantly longer hospital stay (9.6 ± 6.2 vs 6.2 ± 3.1 days, p<0.001) and a higher incidence of complications in respiratory and cardiovascular systems. Furthermore, AKI developed significantly more in patients in the HA group (58% vs. 18%, p<0.001) as compared to the NA group. The overall incidence of AKI was 23.1%; of which, 14.9%, 7.0%, and 1.2% of cases were classified as Risk, Injury, and Failure, respectively. The serum albumin level correlated with AKI severity (3.4 ± 0.5 vs 3.0 ± 0.5 vs 2.6 ± 0.3, p<0.05). In a multivariate logistic regression analysis for predicting AKI, age, presence of co-morbidities such as chronic kidney disease, total bilirubin, leukocytosis, and hypoalbuminemia were significant predictors for AKI.

Conclusion

Serum albumin level is helpful to predict the development and severity of scrub typhus-associated AKI.

Introduction

Scrub typhus, caused by infection with Orientia tsutsugamushi, is a major cause of febrile illness in Southeast Asia [1]. The clinical spectrum of scrub typhus is wide, ranging from mild and probably subclinical to severe and fatal [24]. Severe complications of scrub typhus include pneumonitis, acute respiratory distress syndrome, meningitis, myocarditis, acute kidney injury (AKI), or even multiple organ failure, which may lead to death [46]. Thus, it becomes essential for clinicians to detect complications during the initial presentation.

The incidence of AKI among scrub typhus patients varies from 21 to 43% [79], and comorbidities, and biomarkers such as serum neutrophil gelatinase-associated lipocalin, are regarded as predictors for AKI in patients with scrub typhus [9, 10]. Hypoalbuminemia (HA) is known to be associated with complications and mortality in patients with acute infectious diseases [11] and has been correlated with an increased risk of AKI occurrence [12, 13]. Previous studies have shown that HA in scrub typhus was closely related to the frequency of various complications including AKI [14, 15]. However, the sample size of previous studies was relatively small, and there was no literature on whether hypoalbuminemia correlated with AKI severity based on the RIFLE criteria.

Therefore, we investigated the clinical significance of hypoalbuminemia in patients with scrub typhus complicated by AKI.

Methods

Patient selection

Between 2009 and 2018, we reviewed 628 patients with an acute febrile illness and a rash who were diagnosed with scrub typhus confirmed by a positive IgM ELISA (enzyme-linked immunosorbent assay) (InBios International Inc., Seattle, WA) for scrub typhus. Patients who were transferred to another hospital for a higher level of care, or to be treated nearer to their own homes during the course of treatment or had concomitant infections like leptospirosis, malaria, or dengue fever were excluded from the study. In addition, patients who were not admitted to our hospital were excluded from this study. We also excluded patients who were not followed-up during the complete recovery in their renal function or for at least three months after discharge. However, we included patients who were transferred from a local hospital after their baseline renal function had been checked. Therefore, a total of 611 patients were enrolled in this study and were divided into two groups [normoalbuminemia (NA) vs. HA] based on the serum albumin level of 3.0 g/dL. This study was approved by the Institutional Review Board of the Presbyterian Medical Center, Jeonju, South Korea (IRB No. 2020-04-017).

Clinical and laboratory information

The patients’ baseline demographic, clinical, and laboratory data were reviewed at the time of hospitalization and during the follow-up period. Detailed clinical histories of all patients were determined and they underwent thorough physical and biochemical examinations. A standard set of investigations including the following were carried out: complete blood counts, liver function and renal function tests, chest radiograph, three peripheral blood smears for malaria, urinalysis (including urea and electrolytes), two blood cultures, and a standard set of febrile serological investigations including an ELISA for the detection of scrub typhus (InBios International Inc., Seattle, WA). To differentiate between endemic zoonoses including leptospirosis and hemorrhagic fever with renal syndrome (HFRS), another serological work-up was performed. Leptospirosis was diagnosed by a ≥ 4-fold rise in indirect immunofluorescent assay (IFA) titer in paired serum samples, or an antibody titer ≥ 1:800 in one serum sample by the microscopic agglutination test. HFRS was diagnosed by a single titer ≥1:80 or ≥ 4-fold rise in IFA titer in paired serum samples.

The complications were defined based on the presence of dysfunction of the following organ systems: 1) Cardiovascular system—presence of any of the following: systolic blood pressure <90 mmHg, myocarditis (defined using the diagnostic criteria for clinically suspected myocarditis presented by the European Society of Cardiology [16]), or new-onset cardiac arrhythmia including atrial fibrillation or supraventricular tachycardia; 2) Respiratory system—presence of any of the following: acute respiratory failure (defined not only by the incidence of hypoxemia, hypercapnia, or the failure to maintain both within a normal range, but also by the presence of any condition that resulted in the need for mechanical ventilation), pneumonia, pleural effusion, pulmonary edema, focal atelectasis, patchy consolidation on chest radiograph or acute distress syndrome; 3) Central nervous system—presence of any of the following: Glasgow Coma Scale ≤12 in the absence of any underlying causes, seizure without underlying causes, meningitis (defined by the presence of headache or nuchal rigidity with either altered sensorium or focal neurological deficits on history or examination, and with cerebrospinal fluid cell counts ≥5 leukocytes/mm3); 4) Urinary system—presence of AKI, defined based on the RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) criteria; 5) Gastrointestinal and hepatobiliary system—presence of any of the following: presence of hepatitis (defined as an elevation of serum transaminases more than five times the normal upper limit), or hyperbilirubinemia as serum total bilirubin >2 mg/dL, or gastrointestinal bleeding [9, 1719].

Patients with AKI were categorized into the Risk (R), Injury (I) and, Failure (F) [20]. The estimated glomerular filtration rate (eGFR) was estimated using the abbreviated Modification of Diet in Renal Disease (MDRD) equation [21]. When the baseline renal function was not obtainable, it was calculated using the standard four-variable MDRD formula, assuming an eGFR of 75 mL/min/1.73 m2. The RIFLE class was determined according to the worst of either the serum creatinine, or eGFR, and urine output criteria. Renal replacement therapy including intermittent hemodialysis was initiated using standard indications. All data are presented as mean ± standard deviation unless otherwise specified. The baseline characteristics of patients in the two groups were compared using t-tests, the chi-square test, or Fisher’s exact test, as appropriate. The clinically relevant parameters or the variables that were significantly associated with the presence of AKI in the univariate analysis were included in the multivariate analysis. The AKI group was further grouped into three subgroups, then serum albumin level was compared among the three subgroups by the one-way analysis of variance followed by post Hoc analysis. A p-value of <0.05 was considered statistically significant. Statistical analysis was carried out using SPSS version 22.0 (IBM Corp., Armonk, NY).

Results

Comparison of clinical characteristics between the NA and HA groups

Compared to the patients in NA group, the patients in the HA group were older (73 ± 9 vs. 62 ± 14 years, P<0.001) and had a higher total leukocyte count (9.6 × 103/ mL vs. 6.2 × 103/mL, P<0.001) (Table 1).

Table 1. Comparison of baseline characteristics between NA and HA groups.

NA HA P-value
(n = 533) (n = 78)
Age 62 ± 14 73 ± 9 < 0.001
Male, n(%) 241 (45) 30 (39) NS
Duration of hospital stay, days 6.2 ± 3.1 9.6 ± 6.2 < 0.001
DM, n(%) 90 (17) 19 (24) NS
Hypertension, n(%) 188 (35) 40 (51) 0.005
CKD, n(%) 19 (3) 3 (4) NS
ICU care, n(%) 11 (2.1) 16 (20.5) < 0.001
Hemoglobin (mg/dl) 12.8 ± 1.6 11.5 ± 1.6 < 0.001
Complications
Gastrointestinal tract, n (%) 68 (13) 8 (10) NS
Respiratory system 73 (14) 39 (50) < 0.001
Cardiovascular system 58 (11) 22 (28) < 0.001
Central nervous system 4 (0.8) 5 (6.4) 0.002
Acute kidney injury 96 (18) 45 (58) < 0.001
Leukocyte (×103/ mL) 6.7 ± 4.1 10.2 ± 3.8 < 0.001
Platelet count (×103/ mL) 141± 57 122 ± 48 0.006
Total bilirubin level 0.7 ± 0.4 0.7 ± 0.7 NS
Serum albumin (mg/dl) 3.7 ± 0.4 2.7 ± 0.2 < 0.001
Serum ALT (IU/L) 91 ± 129 76 ± 56 NS
Creatinine (mg/dl) 1.0 ± 0.4 1.3 ± 0.8 < 0.001
eGFR ml/min/1.73m2 71 ± 24 50 ± 25 < 0.001

The duration of the hospital stay was longer for patients in HA group than NA group (9.6 ± 6.2 vs 6.2 ± 3.1 days, p<0.001). Furthermore, the patients in HA group required ICU care more frequently than those in NA group (20.5% vs 2.1%, P<0.001). The HA group also had a higher incidence of complications in the respiratory (50% vs 14%, P<0.001), cardiovascular (28% vs 11%, P<0.001), and neurologic systems (6.4% vs 0.8%, P = 0.002). In addition, AKI (58% vs 18%, P<0.01) developed more frequently in HA group than in NA group. The plasma ALT concentrations did not differ between the two groups, whereas the eGFR on admission (50 ± 25 ml/min/1.73m2 vs. 71 ± 24 ml/min/1.73m2, P<0.001) was lower in the HA group than in NA group.

Comparison of clinical characteristics between the non-AKI group and AKI group

Compared to patients in the non-AKI group, the patients in the AKI group were older (71 ± 11 vs. 62 ± 14 years, P<0.001) and had a higher incidence of comorbidities, such as hypertension, diabetes, or chronic kidney disease (Table 2).

Table 2. Comparison of baseline characteristics between AKI and non-AKI group.

Non-AKI AKI P-value
(n = 470) (n = 141)
Age 62 ± 14 71 ± 11 < 0.001
Male, n(%) 200 (43) 71 (50) NS
Duration of hospital stay, days 6.1 ± 2.7 8.4 ± 5.7 < 0.001
DM, n(%) 66 (14) 43 (31) < 0.001
Hypertension, n(%) 138 (29) 90 (64) < 0.001
CKD, n(%) 5 (1) 17 (12) < 0.001
Hemoglobin (mg/dl) 12.9 ± 1.6 12.1 ± 1.9 < 0.001
Leukocyte (×103/ mL) 6.5 ± 4.0 9.3 ± 4.3 < 0.001
Platelet count (×103/ mL) 143 ± 57 121 ± 53 < 0.001
Total bilirubin level (mg/dl) 0.7 ± 0.3 0.8 ± 0.6 NS
Serum albumin (mg/dl) 3.7 ± 0.5 3.2 ± 0.5 < 0.001
Serum ALT (IU/L) 90 ± 119 83 ± 133 NS
Creatinine (mg/dl) 0.8 ± 0.2 1.5 ± 0.7 < 0.001
eGFRml/min/1.73m2 78 ± 20 39 ± 17 < 0.001

In addition, patients in the AKI group had poorer renal function (39 ± 17 vs. 78 ± 20 mL/min/1.73m2, P<0.01) on admission and had a higher total leukocyte count (10.01 × 103/ mL vs. 6.78 × 103/mL, P<0.01). The plasma ALT concentrations did not differ between the two groups. However, the serum albumin level (3.2 ± 0.5 mg/dL vs. 3.7 ± 0.5 mg/dL, P<0.001) was lower in the AKI group than that of the non-AKI group.

The relationship between serum albumin and acute kidney injury

Among patients with AKI, 15 (11%) were oliguric (Table 3).

Table 3. Clinical characteristics of 141 patients with AKI.

Non-oliguric 15 (11)
FENa < 1%, n (%)a 53 (64)
Recovery of renal function within 72 h, n (%) 138 (98)
Renal function
    eGFR adm, ml/min/1.73m2 39 ± 17
    eGFR low, ml/min/1.73m2 36 ± 16
    eGFR rec, ml/min/1.73m2 74 ± 21
Urinalysis results
    Proteinuria 15 (32)
    Pyuria 5 (10)
    Hematuria 1 (2)
    Normal 26 (56)

FENa: fractional excretion of sodium

a FENa was available in 83 patients.

eGFR adm, ml/min/1.73m2: eGFR at the time of admission

eGFR low, ml/min/1.73m2: eGFR at lowest value in hospital

eGFR rec, ml/min/1.73m2: eGFR at the time of recovery

One hundred and thirty-five patients had AKI prior to admission and 6 patients experienced AKI during their hospitalization. Of the 141 patients with AKI, 133 experienced a return to their baseline renal function within 72 hours after admission. Of the 83 patients with available fractional excretion of sodium (FENa) data, 53 (64%) had a FENa < 1%. Applying the RIFLE criteria, 91 (64.5%), 43 (30.5%), and 7 (5.0%) patients were classified into the R, I, and F categories, respectively. The mean serum albumin concentrations differed among categories (Risk: 3.4 ± 0.5 mg/dL vs. Injury: 3.0 ± 0.5 mg/dL vs. Failure: 2.6 ± 0.3 mg/dL, P<0.005) (Fig 1).

Fig 1. The mean serum albumin concentrations among categories in patients with AKI.

Fig 1

The serum albumin level correlated with AKI severity. ap<0.05 vs. Risk, bp<0.05 vs. Risk, cp<0.05 vs. Injury.

On univariate analysis, age, presence of comorbidities, such as hypertension, diabetes, or chronic kidney disease, hemoglobin, thrombocytopenia, total leukocyte count, and hypoalbuminemia were significant predictors of AKI. After adjusting for these factors in multivariate logistic regression analysis, the presence of comorbidities, leukocytosis, and hypoalbuminemia were significant predictors of AKI (Table 4).

Table 4. Predictors of AKI (univariative and multivariative analysis).

Univariate Multivariate
HR (95% CI) p-value HR (95% CI) p-value
Age 1.054 (1.036–1.072) <0.001 1.019 (0.999–1.040) 0.064
DM 2.686 (1.725–4.183) <0.001 2.037 (1.179–3.519) 0.011
Hypertension 4.246 (2.855–6.313) <0.001 2.337 (1.449–3.769) 0.001
CKD 12.750 (4.613–35.239) <0.001 8.265 (2.868–28.528) <0.001
Hemoglobin 1.324 (1.178–1.488) 0.703 1.003 (0.866–1.162) 0.963
Leukocytosis 1.179 (1.120–1.242) <0.001 1.130 (1.069–1.195) <0.001
Platelet 1.006 (1.002–1.009) <0.001 1.005 (1.000–1.009) 0.051
Hypoalbuminemia 5.239 (3.469–7.912) <0.001 2.925 (1.722–4.967) <0.001

Discussion

Patients with HA showed a higher incidence of scrub typhus-associated complications including AKI in this study. Furthermore, HA was a significant predictor for scrub typhus-associated AKI and correlated with AKI severity. Therefore, our findings provide a rationale for close monitoring and aggressive therapy in patients with scrub typhus and HA.

In general, HA is associated with complications and mortality in patients with acute infectious diseases. HA is also frequently observed in scrub typhus with a rate of 25–69% [14, 22], and the association between HA and scrub typhus-related complications have been reported in previous studies [14, 15]. These findings were also observed in our study, where patients with HA experienced various complications more frequently in comparison to the NA group. Compared to previous studies, ours has the advantage of having enrolled in a larger sample. Therefore, the relationship between HA and scrub typhus-related complications was demonstrated in our study using a large cohort. In this study, the incidence of hypoalbuminemia was found to be 12.8%, which is relatively lower than that reported previously (25–69.2%) [14, 22, 23]. We believe that this finding might be due to referral bias. The incidence of HA found in previous literature is based on data from tertiary care centers; those data were obtained from severe scrub typhus cases [14, 22]. In contrast, our hospital is a secondary care center adjacent to a rural area. Thus, many patients may seek treatment at our hospital while suffering from an early-stage infection that has not yet progressed to a severe stage. Furthermore, some patients showing severe scrub typhus were transferred from our hospital to a tertiary care center. Indeed, the AKI incidence was found to be 23.1% in the present study, whereas Hwang et al. reported that the AKI incidence based on RIFLE criteria among scrub typhus cases in a tertiary care center was 35.9% [23].

The occurrence of HA in patients with scrub typhus seems to be multifactorial; poor dietary intake, decreased synthesis of albumin due to hepatic dysfunction, increased catabolism of protein, and proteinuria are all known to be related to hypoalbuminemia in cases of acute infectious disease [11, 14]. The central pathophysiological change associated with scrub typhus is vasculitis and perivasculitis of multiple organs due to the destruction of the endothelial cell lining of small blood vessels and perivascular inflammatory cell infiltration [2426]. This consequently results in increased vascular permeability with extravascular protein loss. Such a pathomechanism might also contribute to the development of hypoalbuminemia in patients with scrub typhus. Previous studies have demonstrated patients with scrub typhus and HA to have multiple clinical symptoms according to the involved organs [14, 22]; this was also found in the present study. Therefore, it is important to monitor patients closely with scrub typhus with HA.

Among complications in patients with scrub typhus, the development of AKI is clinically important since it is associated with a longer hospital stay and mortality [27, 28]. Old age, comorbidities, hyperbilirubinemia, and biomarkers are known to be risk factors for predicting AKI [9, 10, 29]. Although the association between HA and AKI was not clear in previous studies, a recent study with a larger cohort including our data showed that HA could be a predictor for AKI in scrub typhus [23]. Even though the exact mechanism of AKI development in scrub typhus is not understood, pre-renal factors such as volume depletion, ischemic acute tubular necrosis, and sepsis were regarded as frequent causes of AKI in this population with infectious diseases [12]. In our study, the majority (94%) of patients with AKI either had FENa < 1% or returned to baseline renal function within 72 hours, both of which are suggestive of pre-renal failure. Other patients had fractional sodium excretion >1% and recovered to their baseline renal function over 72 hours. Therefore, although various mechanisms might have contributed to the scrub typhus-associated AKI, we propose that HA is associated with pre-renal failure in scrub typhus-associated AKI.

A negative correlation between serum albumin level and serum creatinine concentration was reported in the study by Kim et al., whose participants had a hemorrhagic fever with renal syndrome [30]. However, such a relationship was not demonstrated in scrub typhus-associated AKI. In this study, the serum albumin level on admission was not only a significant predictor of AKI but was also associated with AKI severity based on the RIFLE criteria. Furthermore, patients with HA had a longer hospital stay and required ICU care more frequently compared to patients in NA group. In this study, although the majority of AKI patients recovered their renal function within 72 hours in this study, the eGFR on admission always did not consistent with the lowest value during hospitalization. Therefore, it is especially important to check the serum albumin level to predict the clinical course and prognosis of patients with scrub typhus.

Our study had some limitations. First, this was a retrospective and a single-center study. Second, we did not enroll the data from patients that were treated in the outpatient clinic. Thus, it is possible that we excluded patients with a mild type of scrub typhus. Therefore, a large prospective randomized controlled study is needed to investigate further whether HA could predict the development of AKI and its severity.

Patients with scrub typhus with HA had various complications including AKI. The incidence of scrub typhus-associated AKI in our study was 23.1%. HA was a significant predictor for scrub typhus-associated AKI and correlated with AKI severity. Therefore, in cases of scrub typhus-associated AKI, checking serum albumin on admission is important to make a therapeutic approach.

Supporting information

S1 File. The minimal data set, including the study population characteristics, in this study.

(SAV)

Abbreviation

HA

hypoalbuminemia

AKI

acute kidney injury

NA

normoalbuminemia

AST

aspartate aminotransferase

ALT

alanine aminotransferase

DM

diabetes mellitus

CKD

chronic kidney disease

eGFR

estimated glomerular filtration rate

MDRD

Modification of Diet in Renal Disease

FENa

fractional excretion of sodium

ICU

intensive care unit

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

Unfunded study The authors received no specific funding for this work.

References

  • 1.Silpapojakul K. Scrub typhus in the Western Pacific region. Ann Acad Med Singap. 1997; 26: 794–800. . [PubMed] [Google Scholar]
  • 2.Varghese GM, Abraham OC, Mathai D, et al. Scrub typhus among hospitalized patients with febrile illness in South India: magnitude and clinical predictors. J Infect 2006; 52: 56–60. 10.1016/j.jinf.2005.02.001 [DOI] [PubMed] [Google Scholar]
  • 3.Mahajan SK. Scrub typhus. J Assoc Physician India 2005; 53: 954–958. [PubMed] [Google Scholar]
  • 4.Mandell GL, Douglas JR, Bennett JE. Principles and practice of infectious disease. 7th ed. Philadelphia: Churchill Livingstone; 2010; 2529–2530 [Google Scholar]
  • 5.Slipapojakul K, Ukkachoke C, Krisananpan S, Silpapojakul K. Rickettsia meningitis and encephalitis. Arch Intern Med1991;151:1753–1757. [PubMed] [Google Scholar]
  • 6.Hsu GJ, Young T, Peng MY, Chang FY, Chou MY, Sheu LF. Acute renal failure associated with scrub typhus: report of a case. J Formos Med Assoc 1993; 92: 475–477. [PubMed] [Google Scholar]
  • 7.Basu G, Chrispal A, Boorugu H, et al. Acute kidney injury in tropical acute febrile illness in a tertiary care center-RIFLE criteria validation. Nephrol Dial Transplant 2011; 26: 524–531. 10.1093/ndt/gfq477 [DOI] [PubMed] [Google Scholar]
  • 8.Attur RP, Kuppasamy S, Bairy M, et al. Acute kidney injury in scrub typhus. Clin Exp Nephrol 2013; 17: 725–729. 10.1007/s10157-012-0753-9 [DOI] [PubMed] [Google Scholar]
  • 9.Sun IO, Kim MC, Park JW, et al. Clinical characteristics of acute kidney injury in patients with scrub typhus-RIFLE criteria validation. J Infect Chemother 2014; 20: 93–96. 10.1016/j.jiac.2013.08.007 [DOI] [PubMed] [Google Scholar]
  • 10.Sun IO, Shin SH, Cho AY, Yoon HJ, Chang MY, Lee KY. Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus. PloS One 2017;12: e0175890. 10.1371/journal.pone.0175890 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Carratalà J, Rosón B, Fernandez-Sabe N, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 2003; 22: 151–157. 10.1007/s10096-003-0902-x [DOI] [PubMed] [Google Scholar]
  • 12.Wiedermann CJ, Wiedermann W, Joannidis M. Causal relationship between hypoalbuminemia and acute kidney injury. World J Nephrol 2017; 6: 176–187. 10.5527/wjn.v6.i4.176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 2010; 36: 1657–1665. 10.1007/s00134-010-1928-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lee CS, Min IS, Hwang JH, Kwon KS, Lee HB. Clinical significance of hypoalbuminemia in outcome of patients with scrub typhus. BMC Infect Dis 2010; 10: 216. 10.1186/1471-2334-10-216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jayaprakash V, Vamsikrishna M, Indhumathi E, Jayakumar M. Scrub typhus-associated acute kidney injury: A study from a south Indian tertiary care hospital. Saudi J Kidney Dis Transpl 2019; 30: 883–890. 10.4103/1319-2442.265464 [DOI] [PubMed] [Google Scholar]
  • 16.Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636–2648. 10.1093/eurheartj/eht210 [DOI] [PubMed] [Google Scholar]
  • 17.Sriwongpan P, Krittigamas P, Kantipong P, Kunyanone N, Patumanond J, Namwongprom S. Clinical indicators for severe prognosis of scrub typhus. Risk Manag Healthc Policy 2013; 6: 43–49. 10.2147/RMHP.S52470 eCollection 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kim MH, Kim SH, Choi JH, Wie SH. Clinical and laboratory predictors associated with complicated scrub typhus. Infect Chemother 2019; 51: 161–170. 10.3947/ic.2019.51.2.161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yang HJ, Kim SM, et al. Clinical significance of abnormal chest radiographic findings for acute kidney injury in patients with scrub typhus. Kidney Res Clin Pract 2020; 39: 54–59. 10.23876/j.krcp.19.122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204–212. 10.1186/cc2872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766–772. 10.1373/clinchem.2006.077180 [DOI] [PubMed] [Google Scholar]
  • 22.Song SW, Kim KT, Ku YM, et al. Clinical role of interstitial pneumonia in patients with scrub typhus: a possible marker of disease severity. J Korean Med Sci 2004; 19: 668–673. 10.3346/jkms.2004.19.5.668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hwang K, Jang HN, Lee TW, et al. Incidence, risk factors and clinical outcomes of acute kidney injury associated with scrub typhus: a retrospective study of 510 consecutive patients in South Korea (2001–2013). BMJ Open 2017; 15: e013882 10.1136/bmjopen-2016-013882 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Strickman D, Smith CD, Corcoran KD, et al. Pathology of rickettsia tsutsugamushi infection in bandicota savilei, a natural host in Thailand. Am J Trop Med Hyg 1994, 51: 416–423. [PubMed] [Google Scholar]
  • 25.Kim SJ, Chung IK, Chung IS, Song DH, Park SH, Kim HS, et al.: The clinical significance of upper gastrointestinal endoscopy in gastrointestinal vasculitis related to scrub typhus. Endoscopy 2000, 32: 950–955. 10.1055/s-2000-9621 [DOI] [PubMed] [Google Scholar]
  • 26.Seong SY, Choi MS, Kim IS: Orientia tsutsugamushi infection: Overview and immune responses. Microbes Infect 2001, 3: 11–21. 10.1016/s1286-4579(00)01352-6 [DOI] [PubMed] [Google Scholar]
  • 27.Singbartl K, Joannidis M. Short-term Effects of Acute Kidney Injury. Crit Care Clin 2015; 31: 751–762. 10.1016/j.ccc.2015.06.010 [DOI] [PubMed] [Google Scholar]
  • 28.Hsu RK, McCulloch CE, Heung M, et al. Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team: Exploring Potential Reasons for the Temporal Trend in Dialysis-Requiring AKI in the United States. Clin J Am Soc Nephrol 2016; 11: 14–20. 10.2215/CJN.04520415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sharma R, Mahajan SK, Singh B, Raina R, Kanga A. Predictors of severity in scrub typhus. J Assoc Physicians India 2019; 67: 35–38. [PubMed] [Google Scholar]
  • 30.Kim YO, Yoon SA, Ku YM, et al. Serum albumin level correlates with disease severity in patients with hemorrhagic fever with renal syndrome. J Korean Med Sci 2003; 18: 696–700. 10.3346/jkms.2003.18.5.696 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Bhagwan Dass

8 Jan 2021

PONE-D-20-35972

Clinical significance of hypoalbuminemia in patients with scrub typhus complicated by acute kidney injury

PLOS ONE

Dear Dr.In O Sun

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 After reviewing  the manuscript.I would suggest to please incoprorate the changes as advised by the reviewers in the  article.

Please submit your revised manuscript by Feb 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Bhagwan Dass, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the data extraction tool used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a data extraction tool as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

3. In statistical methods, please refer to any post-hoc corrections to correct for multiple comparisons during your statistical analyses. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting).

4. As part of your revision, please complete and submit a copy of the RECORD checklist, a document that aims to improve reporting and reproducibility of observational studies that use routinely-collected data for purposes of post-publication data analysis and reproducibility: (http://record-statement.org). Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"The authors wish to acknowledge the financial support of the Christian Medical Research

Center, Presbyterian Medical Center, Jeonju, Korea."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"Unfunded study

The authors received no specific funding for this work. "

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found some minor occurrences of overlapping text with the following previous publication(s), some of which you are an author, which needs to be addressed:

- https://e-sciencecentral.org/articles/pubreader/SC000036783

- https://www.jiac-j.com/article/S1341-321X(13)00033-0/fulltext

- https://synapse.koreamed.org/articles/1128479

We would like to make you aware that copying extracts from previous publications word-for-word, especially outside the methods section, is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications.

Please revise the manuscript to quote or rephrase the duplicated text and cite your sources for text outside the methods section. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This article poses a clear hypothesis that is fully supported by the data and statistical analysis. The article is clearly written, exhibits good grammar and prose, and the results are clinically relevant. Clinicians may potentially use the findings to direct the level of monitoring various patients receive. Would recommend for publication.

Reviewer #2: The authors present a case series of patients diagnosed with scrub typhus admitted to a medical center in South Korea. They demonstrate that hypoalbuminemia detected on presentation was associated with acute kidney injury, correlated well with severity of the AKI by RIFLE criteria, and was associated with other systemic complications. They further state that multiple clinical and laboratory findings were predictive of AKI by multivariate analysis, which may warrant change to assessment, monitoring, or therapeutic approach.

My assessment of their submission is hampered by duplication of Table 1 in the listed Table 2.

The introduction discusses other publications addressing scrub typhus, its complications, association with renal failure specifically, and association with other complications. The strengths of this analysis by comparison included a larger sample size and use of RIFLE criteria to demonstrate correlation of severity of AKI with severity of hypoalbuminemia. It is interesting that the rate of hypoalbuminemia in this study was lower than others. I would explicitly state whether others included inpatients, outpatients, or both as that is an important limitation of this study.

The section on patient selection should explicitly state whether patients were inpatients, outpatients, or both, and whether they included patients transferred in from another facility. Later in the manuscript, it is stated they excluded outpatients. Also, they exclude patients transferred to other facilities, but it would be helpful to state if it is known why those patients were transferred, especially if it was to a higher level of care.

Elevation of cardiac biomarkers was stated to define myocarditis--this is not accurate and could be stated more accurately as a marker of such. Respiratory complications included ARDS and various imaging findings, but not respiratory failure or mechanical ventilation.

Table 3 should include definition of terms by cutoff values. FENa has a marker for footnote 'a' but no associated footnote and n(%) appear incorrect. If a large number of cases did not have FENa or urinalysis available, I question the value of including that information. Was it assessed whether these cases are representative of the population?

A bigger question is whether HA as an independent biomarker of AKI risk is significant in this setting. It correlated well with AKI and other poor outcomes, but as a negative acute phase reactant, one would expect that to be true. The homeostasis of albumin is affected by numerous factors other than vascular permeability. During acute inflammatory syndromes, synthesis is suppressed and catabolism increased in addition to increased volume of distribution. The "central pathomechanism" comment is incomplete. I would direct to the discussion cited as a reference in Lee, et al. (BMC Infect Dis 2010).

The fact that almost all cases with AKI were present on admission makes HA a marker for a condition that was already present on admission, not a predictor that it will occur. Does HA predict which cases with AKI will progress to a more significant degree of AKI, or which cases that present with HA and normal renal function will progress to AKI? Would it predict which of the 2% of cases will not recover?

Reviewer #3: The authors must be complemented on writing about this very important infectious disease.

I had a few queries:

1. In page 11 could you elaborate further and explain how definiitons for cardiac and respiratory complications were arrived at

2. How was meningoencephalitis identified

3. Under discussion : "The development of HA in

patients with scrub typhus seems to be due to the central pathomechanism of scrub typhus,

which is vasculitis or perivasculitis of multiple organs resulting in increased vascular

permeability". Could you please provide a reference.

4. Further explanation of who were included in the study is warranted. We would like to know what work up was done for patients presenting with fever and a rash. What other causes were ruled out.

5.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 25;16(2):e0247584. doi: 10.1371/journal.pone.0247584.r002

Author response to Decision Letter 0


4 Feb 2021

Thank you for reviewing our manuscript. We have changed the contents one by one according to your comments. Thank you so much.

Attachment

Submitted filename: Response to reviewer comments.docx

Decision Letter 1

Bhagwan Dass

10 Feb 2021

Clinical significance of hypoalbuminemia in patients with scrub typhus complicated by acute kidney injury

PONE-D-20-35972R1

Dear Dr. Sun,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Bhagwan Dass, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Bhagwan Dass

16 Feb 2021

PONE-D-20-35972R1

Clinical significance of hypoalbuminemia in patients with scrub typhus complicated by acute kidney injury

Dear Dr. Sun:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Bhagwan Dass

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. The minimal data set, including the study population characteristics, in this study.

    (SAV)

    Attachment

    Submitted filename: Response to reviewer comments.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES